相似文献
1
Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology.阿尔蒂·胡里亚医学博士：向她在肿瘤临床试验联盟中留下的光辉遗产致敬。
J Geriatr Oncol. 2020 Mar;11(2):179-183. doi: 10.1016/j.jgo.2019.05.011. Epub 2019 Jun 11.
2
Geriatricizing clinical trials: The legacy of Arti Hurria, MD.使临床试验老年化：医学博士阿蒂·胡里亚的遗产
J Geriatr Oncol. 2020 Mar;11(2):149-150. doi: 10.1016/j.jgo.2019.09.014. Epub 2019 Nov 8.
3
Tribute to Arti Hurria, M.D.向医学博士阿尔蒂·胡里亚致敬
J Geriatr Oncol. 2019 Jan;10(1):1-3. doi: 10.1016/j.jgo.2018.11.003. Epub 2018 Dec 1.
4
A tribute to Arti Hurria by the International Society of Geriatric Oncology (SIOG).国际老年肿瘤学会（SIOG）对阿尔蒂·胡里亚的致敬。
J Geriatr Oncol. 2020 Mar;11(2):160-161. doi: 10.1016/j.jgo.2019.07.016. Epub 2019 Jul 19.
5
A story of connection: A tribute to Arti Hurria, MD.一段关于联系的故事：向医学博士阿尔蒂·胡里亚致敬。
J Geriatr Oncol. 2020 Mar;11(2):164-165. doi: 10.1016/j.jgo.2019.07.021. Epub 2019 Aug 8.
6
Cancer and aging activities at the American Society of Clinical Oncology and beyond: Reflections on the legacy of Dr. Arti Hurria.美国临床肿瘤学会及其他机构的癌症与衰老相关活动：缅怀阿尔蒂·胡里亚博士的贡献
J Geriatr Oncol. 2020 Mar;11(2):151-153. doi: 10.1016/j.jgo.2019.07.007. Epub 2019 Jul 15.
7
Arti Hurria and the progress in integrating the geriatric assessment into oncology: Young International Society of Geriatric Oncology review paper.阿提·胡里亚和将老年评估纳入肿瘤学的进展：年轻的国际老年肿瘤学会评论论文。
J Geriatr Oncol. 2020 Mar;11(2):203-211. doi: 10.1016/j.jgo.2019.08.005. Epub 2019 Aug 23.
8
Lessons Learned from Arti-Collaborating to Improve Care: the Past, Present, and Future of the Cancer and Aging Research Group.从 Arti-Collaborating 中吸取的经验教训以改善护理：癌症与老龄化研究小组的过去、现在和未来。
J Am Geriatr Soc. 2019 May;67(5):879-883. doi: 10.1111/jgs.15935.
9
Special issue to honor and remember Dr. Arti Hurria: Call for papers for the Journal of Geriatric Oncology.纪念阿尔蒂·胡里亚博士的特刊：《老年肿瘤学杂志》征稿启事。
J Geriatr Oncol. 2019 Mar;10(2):179. doi: 10.1016/j.jgo.2019.01.014. Epub 2019 Feb 2.
10
Leadership in action: Emulating Arti Hurria.行动中的领导力：效仿阿尔蒂·胡里亚。
J Geriatr Oncol. 2020 Mar;11(2):154-155. doi: 10.1016/j.jgo.2019.12.009. Epub 2019 Dec 25.
引用本文的文献
1
Understanding Treatment Tolerability in Older Adults With Cancer.了解老年癌症患者的治疗耐受性
J Clin Oncol. 2021 Jul 1;39(19):2150-2163. doi: 10.1200/JCO.21.00195. Epub 2021 May 27.
2
Older adults with cancer and their caregivers - current landscape and future directions for clinical care.癌症老年患者及其照护者——临床照护的现状和未来方向。
Nat Rev Clin Oncol. 2020 Dec;17(12):742-755. doi: 10.1038/s41571-020-0421-z. Epub 2020 Sep 2.
本文引用的文献
1
Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).老年患者癌症临床试验：2277 例患者的汇总分析（A151715）。
Oncologist. 2019 Jun;24(6):e284-e291. doi: 10.1634/theoncologist.2018-0803. Epub 2019 Apr 11.
2
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.伊布替尼方案与化疗免疫治疗在未经治疗的老年 CLL 患者中的比较。
N Engl J Med. 2018 Dec 27;379(26):2517-2528. doi: 10.1056/NEJMoa1812836. Epub 2018 Dec 1.
3
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.年龄与早期乳腺癌女性接受紫杉醇诱导的神经病变风险的关系（Alliance A151411）：来自癌症和白血病组 B（CALGB）40101 的 1881 例患者的结果。
Oncologist. 2019 May;24(5):617-623. doi: 10.1634/theoncologist.2018-0298. Epub 2018 Nov 8.
4
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.老年女性接受乳腺癌辅助化疗后的功能衰退和恢复能力。
J Am Geriatr Soc. 2019 May;67(5):920-927. doi: 10.1111/jgs.15493. Epub 2018 Aug 26.
5
Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer.功能年龄与实际年龄：老年癌症患者的评估以指导决策。
Lancet Oncol. 2018 Jun;19(6):e305-e316. doi: 10.1016/S1470-2045(18)30348-6. Epub 2018 Jun 1.
6
Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622).对于非小细胞肺癌的老年患者，一线基于铂类的双联化疗是否也有益？来自 730 例前瞻性治疗患者（Alliance 研究 A151622）的汇总分析观察结果。
J Geriatr Oncol. 2018 Sep;9(5):501-506. doi: 10.1016/j.jgo.2018.05.006. Epub 2018 May 27.
7
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.贝伐珠单抗联合来曲唑治疗激素受体阳性晚期乳腺癌患者毒性的危险因素识别：CALGB 40503（alliance）相关性研究。
Breast Cancer Res Treat. 2018 Sep;171(2):325-334. doi: 10.1007/s10549-018-4828-5. Epub 2018 May 22.
8
Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).新型药物在老年慢性淋巴细胞白血病和非霍奇金淋巴瘤患者中导致三级或四级毒性的频率和影响（alliance A151611）。
J Geriatr Oncol. 2018 Jul;9(4):321-328. doi: 10.1016/j.jgo.2018.03.018. Epub 2018 Apr 17.
9
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711).1000 余例晚期非小细胞肺癌患者的治疗失败时间及相关结局：老年患者与年轻患者的比较（Alliance A151711）。
J Thorac Oncol. 2018 Jul;13(7):996-1003. doi: 10.1016/j.jtho.2018.03.020. Epub 2018 Mar 30.
10
The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance).CALGB 49907（Alliance）研究中老年乳腺癌患者对化疗的偏好与癌症相关结局
J Geriatr Oncol. 2018 May;9(3):221-227. doi: 10.1016/j.jgo.2018.02.003. Epub 2018 Mar 28.
Zotero 插件